Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Hatvan – page 28

480 clinical trials in Hatvan, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Hatvan at a glance
480
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

480 trials in Hatvan

Open in trial search

Pain+1

Not recruiting

Comparison of bovine and marine chondroitin sulfate tablets (800 mg) in treating knee osteoarthritis pain and functional impairment

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Chondroitin sulfate (marine)
  • Sponsor:IBSA Institut Biochimique SA

Crohn's disease

Not recruiting

Study of SAR441566 compared to placebo for adults with moderate to severe Crohn's disease

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Balinatunfib
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study Comparing Acasunlimab and Pembrolizumab with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Acasunlimab
  • Sponsor:Genmab A/S

Study Comparing Elacestrant and Standard Endocrine Therapy for Patients with Early Breast Cancer at High Risk of Recurrence

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Stemline Therapeutics Inc.

Migraine

Not recruiting

Study on Atogepant for Preventing Menstrual Migraine in Women

Investigational
Countries:HungaryHungary
  • Participants:18–64 years
  • Substances:Atogepant
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study of PF-06821497 and Enzalutamide for Men with Advanced Prostate Cancer Resistant to Hormone Therapy

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Enzalutamide
  • Sponsor:Pfizer Inc.

Study on the Effectiveness and Safety of ANX007 Injections for Patients with Geographic Atrophy from Age-Related Macular Degeneration

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:ANX007
  • Sponsor:Annexon Inc.

Study of tozorakimab effectiveness and safety in former smokers with Chronic Obstructive Pulmonary Disease (COPD) who experience disease flare-ups

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:Astrazeneca AB

Multiple sclerosis

Not recruiting

Study on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis

Investigational
Countries:HungaryHungary
  • Participants:18–64 years
  • Substances:Frexalimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Colitis ulcerative

Not recruiting

Study on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.

Breast cancer+1

Not recruiting

Study of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Pfizer Inc.

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Hatvan

What the registry says about research in the country

01 Cardiovascular Research

Extensive clinical trials focusing on atherosclerotic cardiovascular disease and innovative treatments for heart conditions, including studies on new medications for heart failure management.

  • Heart Failure Treatment Studies
  • Cardiovascular Disease Prevention
  • Atrial Fibrillation Management

Advanced research evaluating treatments for both preserved and reduced ejection fraction heart failure.

02 Respiratory Medicine

Research initiatives examining treatments for chronic respiratory conditions, with particular focus on asthma and COPD management.

  • Asthma Control Studies
  • COPD Treatment Evaluation
  • Respiratory Drug Development

Innovative trials testing new inhalation devices and medication combinations.

03 Women's Health

Clinical investigations into reproductive health and women's medical conditions, including contraceptive technologies and menstrual health management.

  • Contraceptive Development
  • Primary Dysmenorrhea Treatment
  • Reproductive Health Solutions

Studies evaluating both hormonal and natural treatment approaches.

04 Metabolic Disorders

Research programs targeting metabolic conditions, with emphasis on obesity and lipid disorders management.

  • Obesity Treatment Studies
  • Hypertriglyceridemia Research
  • Cardiovascular Risk Management

Innovative approaches to treating severe metabolic disorders and their complications.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.